drugset / Trial / NCT06218212
The Effect of Renastart Formula Supplementation in Children With Acute Kidney Injury in Maintaining Normal Serum Electrolytes Levels
RandomizedParallel-groupOpen-labelTreatment
Summary
This clinical trial will evaluate Renastart formula effectiveness in children with acute kidney injury (AKI) and acute on top of chronic kidney disease (CKD), in maintaining normal serum electrolytes levels without using electrolyte binders,24 patients will be recruited from Pediatric Nephrology Unit (PNU), Children's Hospital, Ain Shams University, they will be assigned randomly in to two arms, arm 1 including patients who will be treated by electrolytes binders, arm 2 including patients who will be treated by Renastart formula, after initial assessment serum electrolyte evaluation will be followed up monthly for 3 months.
Timeline
- Start
- 2022-02-12
- Primary completion
- 2023-03-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Calcium carbonate | Other / unclassified | 45 mg/kg | Oral |
| Comparator | Calcium carbonate | Other / unclassified | 65 mg/kg | Oral |
| Comparator | sodium polystyrene sulfonate | Other / unclassified | 0.5 mg/kg | Oral |
| Comparator | sodium polystyrene sulfonate | Other / unclassified | 1 mg/kg | Oral |